Cost-effectiveness of the CV-polypill strategy versus standard care for secondary cardiovascular prevention in Spain: an analysis based on the SECURE trial
Authors
Alberto Cordero (ORCID: https://orcid.org/0000-0003-0000-7109)
Cost-effectiveness of the CV-polypill strategy versus standard care for secondary cardiovascular prevention in Spain: an analysis based on the SECURE trial
Alberto Cordero, Ruth Owen, José M. Castellano, Thomas A. Gaziano et al.
Citations
1 citations
Journal
The Lancet Regional Health - Europe
Topics
Medication Adherence and Compliance
Field-Weighted Citation Impact (FWCI)
1.52
article
Cost-effectiveness of the CV-polypill strategy versus standard care for secondary cardiovascular prevention in Spain: an analysis based on the SECURE trial
Alberto Cordero, Ruth Owen, José M. Castellano, Thomas A. Gaziano, Stuart Mealing, Amy Dymond, Stuart Pocock, François Schiele, José Ramón González‐Juanatey, Antonio Fernández‐Ortíz, Lucila María Pérez Fernández, Valentı́n Fuster, Aleš Linhart, Alissa Looby, Wolfram Doehner
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet Regional Health - EuropeVol. 55
Institutions
Brigham and Women's Hospital (US), Harvard University (US), Mario Negri Institute for Pharmacological Research (IT), Spanish National Centre for Cardiovascular Research (ES), Hospital Clínico San Carlos (ES), Centre Hospitalier Universitaire de Besançon (FR), London School of Hygiene & Tropical Medicine (GB), Hospital Universitari Sant Joan D'Alacant (ES), Complejo Hospitalario Universitario de Santiago (ES), Mount Sinai Hospital (US), Deutsches Herzzentrum der Charité (DE), German Centre for Cardiovascular Research (DE), Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE), Instituto de Investigación Sanitaria de Santiago (ES), York District Hospital (US), General University Hospital in Prague (CZ), Charité - Universitätsmedizin Berlin (DE)